Results 41 to 50 of about 694,618 (329)
My atrial fibrillation is not your atrial fibrillation [PDF]
Abstract not available ; Paulus Kirchhof and Prashanthan ...
Paulus Kirchhof+2 more
openaire +4 more sources
Atrial fibrillation (AF) is a hetrogeneous disease that may present in many forms. Advances in our understanding of the mechanism responsible for AF have led to exciting new therapies that may soon provide a definitive cure.
openaire +4 more sources
Background Focal impulse and rotor modulation (FIRM) can cause slowing, organization, and occasionally termination of atrial fibrillation (AF), although results have been mixed.
Peter R. Liu+5 more
doaj +1 more source
Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients
Background: The prognosis of patients with multiple myeloma (MM) is variable and partly depends on their cardiovascular status. The presence of arrhythmias can lead to worse outcomes.
Jie Wang+9 more
doaj +1 more source
Edoxaban versus warfarin in patients with atrial fibrillation.
BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
R. Giugliano+20 more
semanticscholar +1 more source
Introduction. Growing evidence suggests that fibrotic changes can be observed in atrial fibrillation (AF) in both atria. Quantification of the scar burden during electroanatomical mapping might have important therapeutic and prognostic consequences ...
Szilvia Herczeg+7 more
doaj +1 more source
IntroductionScreening for atrial fibrillation and timely initiation of oral anticoagulation, rhythm management, and treatment of concomitant cardiovascular conditions can improve outcomes in high-risk populations.
Larissa Fabritz+25 more
doaj +1 more source
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure
Supplemental Digital Content is available in the text. Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials have reported improved outcomes, including freedom from AF recurrence, quality of life, and survival ...
D. Packer+9 more
semanticscholar +1 more source
Novel concepts in atrial fibrillation ablation—breaking the trade‐off between efficacy and safety
Despite substantial technological and procedural advances that have improved the efficacy and safety of AF ablation in recent years, the long‐term durability of ablation lesions is still not satisfactory.
Till F. Althoff, Lluís Mont
doaj +1 more source
Atrial fibrillation and microRNAs [PDF]
Atrial fibrillation (AF) is the most common sustained arrhythmia, especially in the elderly, and has a significant genetic component. Recently, several independent investigators have demonstrated a functional role for small non-coding RNAs (microRNAs) in the pathophysiology of this cardiac arrhythmia.
Santulli, Gaetano+4 more
openaire +5 more sources